feed,title,long_url,short_url
Benzinga,Why Baozun Shares Are Rising Today,https://benzinga.com/news/earnings/22/05/27416126/baozun-beats-q1-aided-by-value-added-services-as-online-store-revenue-declined,https://bit.ly/3lNWE3o
Benzinga,CytomX Therapeutics Initiates Dosing in Early-Stage Study Of Solid Tumor Settings,https://benzinga.com/general/biotech/22/05/27417467/cytomx-therapeutics-initiates-dosing-in-early-stage-study-of-solid-tumor-settings,https://bit.ly/3wQOeyQ
